Cite
MLA Citation
Andrew P. Wright et al.. “Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation.” Liver transplantation, vol. 23, no. 7, n.d., pp. 968–971. http://access.bl.uk/ark:/81055/vdc_100047471628.0x000013